SCHEMBL890983

SCHEMBL890983

CC(C)OC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29119777 0.97 TSHR (0.48)
SCHEMBL297916 0.83 TSHR (0.59)
SCHEMBL1003135 0.82
SCHEMBL28267250 0.82 TSHR (0.46)
SCHEMBL27926059 0.80 TSHR (0.56)
SCHEMBL5316505 0.79
SCHEMBL11703818 0.78 TSHR (0.42)
SCHEMBL11510451 0.78 TSHR (0.53)
SCHEMBL20565358 0.78 TSHR (0.53)
SCHEMBL16048299 0.78 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119977783-A Synthesis method of oxaloacetic acid 上海高准医药有限公司 2025-05-13 CN claimed
CN-116768795-A Synthesis method of cyenopyrafen intermediate 湖南速博生物技术有限公司 2023-09-19 CN claimed
EP-0026982-A1 Coating compositions containing mono- or diester coalescing agents and a substrate coated therewith ROHM AND HAAS COMPANY (US) 1981-04-15 EP claimed
CN-119977783-A Synthesis method of oxaloacetic acid 上海高准医药有限公司 2025-05-13 CN disclosed
CN-115485276-B Deuterated AKT kinase inhibitors 南京正大天晴制药有限公司 2024-05-31 CN disclosed
CN-117964620-A AKT inhibitors 南京正大天晴制药有限公司 2024-05-03 CN disclosed
CN-113272304-B AKT inhibitors 南京正大天晴制药有限公司 2024-03-29 CN disclosed
CN-115843298-B Salts and crystal forms of dihydropyrido [2,3-d ] pyrimidinone derivative 南京正大天晴制药有限公司 2024-03-29 CN disclosed
CN-115836069-B Salts of dihydropyrido [2,3-d ] pyrimidinone derivatives, preparation method and application thereof 南京正大天晴制药有限公司 2024-02-06 CN disclosed
US-20230321108-A1 UNIT DOSAGE COMPOSITION OF AKT INHIBITOR NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. (CN) 2023-10-12 US disclosed
US-20230271958-A1 SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATE NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. (CN) 2023-08-31 US disclosed
EP-0983268-A1 AMIDINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE Astra Aktiebolag (SE) 2000-03-08 EP disclosed
US-6018072-A SUBJECTING AN ALKYLARYL OXALATE TO A DISPROPORTIONATION REACTION IN THE PRESENCE OF A DISPROPORTIONATION CATALYST TO PRODUCE A DIARYL OXALATE WHILE REMOVING A DIALKYL OXALATE BY-PRODUCT UBE INDUSTRIES, LTD. (JP) 2000-01-25 US disclosed
WO-1998050382-A1 AMIDINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRA AKTIEBOLAG (SE) 1998-11-12 WO disclosed
US-5811573-A Process for producing a diaryl carnonate UBE INDUSTRIES, LTD. (JP) 1998-09-22 US disclosed
US-5731453-A Process for producing a diaryl carbonate UBE INDUSTRIES, LTD. (JP) 1998-03-24 US disclosed
EP-0814074-A1 PROCESS FOR PREPARING DIARYL ESTERS OF OXALIC ACID UBE INDUSTRIES, LTD. (JP) 1997-12-29 EP disclosed
EP-0795539-A1 Process for producing a diaryl carbonate UBE INDUSTRIES LIMITED (JP) 1997-09-17 EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
US-4435048-A LARGE AREA OPTICAL DISPLAY ASAHI GLASS COMPANY LTD. (JP) 1984-03-06 US disclosed